WVE

9.04

8.92% 0.74

Dopo l'orario di chiusura: 8.90 -0.14 -1.55%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$8.30

Aprire:

$8.29

Volume 24 ore:

5.24M

Relative Volume:

2.15

Capitalizzazione di mercato:

$1.44B

Reddito:

$93.95M

Utile/perdita netta:

$-129.87M

Rapporto P/E:

-10.04

EPS:

-0.9

Flusso di cassa netto:

$-202.88M

1 W Prestazione:

+26.79%

1M Prestazione:

+23.50%

6M Prestazione:

+17.10%

1 anno Prestazione:

-34.06%

Intervallo 1D:

$8.175

$9.09

Intervallo di 1 settimana:

$7.16

$9.75

Portata 52W:

$5.28

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1135)

Industria

Biotechnology (635)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

288

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	9.04	1.32B	93.95M	-129.87M	-202.88M	-0.90
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

Nov 02, 2025

Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com

Nov 02, 2025

Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com

Nov 02, 2025

Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade

Nov 02, 2025

Published on: 2025-11-02 11:38:54 - newser.com

Nov 02, 2025

Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com

Nov 02, 2025

What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com

Nov 02, 2025

Heatmap analysis for Wave Life Sciences Ltd. and competitors2025 Winners & Losers & High Accuracy Trade Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Candlestick signals on Wave Life Sciences Ltd. stock today2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com

Nov 01, 2025

Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo

Nov 01, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st

Nov 01, 2025

Can Wave Life Sciences Ltd. stock deliver sustainable ROEWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com

Nov 01, 2025

Oct 31, 2025

Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech

Oct 31, 2025

Can Wave Life Sciences Ltd. recover in the next quarter2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com

Oct 31, 2025

Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025

Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com

Oct 31, 2025

Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com

Oct 31, 2025

Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena

Oct 31, 2025

Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat

Oct 30, 2025

Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat

Oct 30, 2025

A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st

Oct 30, 2025

Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN

Oct 30, 2025

WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan

Oct 30, 2025

Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Nasdaq

Oct 30, 2025

Oct 29, 2025

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire

Oct 29, 2025

Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan

Oct 29, 2025

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.

Oct 29, 2025